Sinopharm: revenue by category 2022 | Statista

In 2022, the Chinese pharmaceutical giant Sinopharm group reported annual revenue of over 552 billion yuan. The vast majority of the company's revenue was generated by the sale of products, including medicine and medical equipment. The widespread adaption of COVID-19 vaccines developed and produced by two subsidiaries of the group also contributed to the growth of the revenue figures.

Revenue of Sinopharm Group Co., Ltd. from 2011 to 2022, by category (in million yuan)

Characteristic	Sales of goods	Financial lease interest income	Consulting income	Logistics services income	Operating lease income	Franchise fees and other service fees from medicine chain stores	Other	Import agency income
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Register for free

Already a member?

Source

Use Ask Statista Research Service

Release date

April 2023

More information

Region

China

Survey time period

2011 to 2022

Supplementary notes

Note: 1 yuan equals approximately 0.14 U.S. dollars and 0.13 euros (as of August 2023).

Figures have been rounded.

Citation formats

Other statistics on the topic
Chinese COVID-19 vaccines

Total number of coronavirus COVID-19 vaccination doses administered in China from December 15, 2020 to June 7, 2022 (in millions)

State of Health

COVID-19 vaccination doses in China 2020-2022

Number of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country

State of Health

COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country

Total number of coronavirus COVID-19 vaccine booster doses administered in China from November 5, 2021 to June 4, 2022 (in millions)

State of Health

COVID-19 vaccine booster doses in China 2021-2022

Share of the elderly population vaccinated against COVID-19 in China as of March 17, 2022, by age group

State of Health

COVID-19 vaccination rate among the elderly population in China 2022, by age group

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year

Basic Account

Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account

The ideal entry-level account for individual users

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$199 USD / Month *

Professional Account

Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Chinese COVID-19 vaccines "

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

Other statistics that may interest you Chinese COVID-19 vaccines

Overview

6

Sinovac

6

Sinopharm and CanSino

6

Domestic adoption

5

Exports

5

Further related statistics

12

Further Content: You might find this interesting as well

Statistics

Topics

Chinese COVID-19 vaccines

Coronavirus COVID-19 in China

Pharmaceutical industry in China

Vaccine industry in China

Coronavirus disease (COVID-19) pandemic

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year

Learn more about how Statista can support your business.